Unraveling the chemotherapeutic potential of taxifolin ruthenium-p-cymene complex in breast carcinoma: Insights into AhR signaling pathway in vitro and in vivo

Background: Mammary carcinoma is the most frequently diagnosed form of carcinoma in women worldwide. The organometallic compounds showed a prospective anticancer activity. This research explored the anticancer efficacy of taxifolin ruthenium-p-cymene counter to breast cancer. Methods: The anticancer...

Cijeli opis

Bibliografski detalji

Glavni autori:	Abhijit Das, Barshana Bhattacharya, Sakuntala Gayen, Souvik Roy
Format:	Artigo
Jezik:	Inglês
Izdano:	Elsevier 2024-11-01
Serija:	Translational Oncology
Teme:	Ruthenium-p-cymene Taxifolin Epithelial-to-mesenchymal transition Breast carcinoma AhR pathway
Online pristup:	http://www.sciencedirect.com/science/article/pii/S1936523324002341
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!